Content on this website is intended for healthcare professionals only.

By clicking on the link below, you confirm you are a healthcare professional (HCP).

I confirm I am a HCP I am not a HCP

Time to Take the Lead – Practical Utilization of SGLT2 Inhibitors

Published: 07 September 2020

  • Views:

    Views Icon 118
  • Likes:

    Heart Icon 0

Overview

Full programme

  • Views:

    Views Icon 118
  • Likes:

    Heart Icon 0

Overview

This educational symposium first broadcast at the ESC Congress 2020 discusses how SGLT2 inhibitors should be utilised by cardiologists in everyday practice

This independent medical education symposium was supported by a grant from the Boehringer Ingelheim & Eli Lilly and Company alliance.

Learning objectives

  • Understand current guidelines and utilisation of SGLT2i
  • Describe the potential mechanism of benefit of SGLT2i
  • Initiate and manage SGLT2i in appropriate patients

Series overview

Part 1

Introduction, and No Permission Needed – Cardiology Guidelines + Prescribing Practice

1 session

  • Introduction, and No Permission Needed – Cardiology Guidelines + Prescribing Practice

    Watch now

Part 2

SGLT2i are Cardiovascular Drugs

1 session

Part 3

Cardiologists Taking the Lead – How Can We Use SGLT2 Inhibitors in Our Clinical Practice?

1 session

  • Cardiologists Taking the Lead – How Can We Use SGLT2 Inhibitors in Our Clinical Practice?

    Watch now

Part 4

Case Discussion

1 session

Part 5

A Follow-up Discussion to the ESC 2020 Session

1 session

  • A Follow-up Discussion to the ESC 2020 Session

    Watch now

Faculty biographies